Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions

Bristol Myers Squibb Co. said Thursday it had a net loss of $10.027.....»»

Shares of Bristol-Myers Squibb were up 2% in premarket trading on Thursday after the company beat earnings estimates for the fourth quarter of 2019. The company had a net loss of $1.1 billion, or 44 cents per share, in the fourth quarter of 2019, a.....»»

Bristol-Myers Squibb (NYSE: BMY) reported third-quarter earnings of $1.17 per share Thursday, beating the analyst consensus estimate of $1.07.  The company reported quarterly sales of $6.007 billion.....»»

Companies Reporting Before The Bell Bristol-Myers Squibb Company (NYSE: BMY) is expected to report quarterly earnings at $1.07 per share on revenue of $5.90 billion. read more.....»»

Companies Reporting Before The Bell Comcast Corporation (NASDAQ: CMCSA) is estimated to report quarterly earnings at $0.75 per share on revenue of $27.08 billion. Bristol-Myers Squibb Company (NYSE: BMY) is expected to report quarterly earnings at .....»»

Companies Reporting Before The Bell Bristol-Myers Squibb Company (NYSE: BMY) is expected to report quarterly earnings at $1.07 per share on revenue of $5.71 billion. read more.....»»

Companies Reporting Before The Bell Bristol-Myers Squibb Company (NYSE: BMY) is expected to post quarterly earnings at $0.85 per share on revenue of $5.99 billion. read more.....»»

The company says it will cut 2,200 jobs this year on its way to shedding $1.5 billion in costs by the end of next year......»»

Bristol-Myers Squibb Company (NYSE: BMY) reported an adjusted loss per share of $4.40, narrower than the Zacks Consensus Estimate of a loss of $4.53 per share. In the year-ago quarter, BMY posted adjusted earnings per share of $2.05. read more.....»»

Bristol Myers Squibb Co. said Monday its board has approved an additional $2 billion of share buybacks, bringing the company's full authorization to about $6.4 bil.....»»

Today's 5 Stock Ideas:  Disney (DIS) - An earnings play. Will report quarterly results after the close on Tuesday, May 5, 2020.  Bristol Myers Squibb (BMY) - A play on upcoming data related to read more.....»»

Ford swings to a surprise GAAP loss and misses adjusted profit expectations for its fourth quarter, sending the stock 8% lower in the extended session......»»

Ford swings to a surprise GAAP loss and misses adjusted profit expectations for its fourth quarter, sending the stock 8% lower in the extended session......»»

Chevron Corp swung to a fourth-quarter loss on $10.4 billion in charges as it stepped up efforts to cull unprofitable assets amid weak oil and gas prices......»»

Altria Group Inc. said Thursday it had a net loss of $1.809 billion, or $1.00 a share, in the fourth quarter, after incom.....»»

Bristol-Myers Squibb Co. on Wednesday said it completed its $74 billion acquisition of Celgene Corp. , nearly a year after announcing the controversial de.....»»

Bristol-Myers Squibb Co. shares rose 0.9% after the company beat earnings estimates but lowered its full-year per-share earnings guidance. The New York-based drug company said it had net income of $1.353 billion,.....»»

Amgen Inc will buy Celgene Corp's psoriasis drug Otezla for $13.4 billion in cash, clearing the way for Bristol-Myers Squibb to go ahead with its $74 billion deal for Celgene by the end of the year......»»

Amgen Inc said on Monday it would buy Celgene Corp's psoriasis drug Otezla for $13.4 billion in cash, clearing the way for Bristol-Myers Squibb to go ahead with its $74 billion deal for Celgene......»»

Celgene Corp will sell its psoriasis drug Otezla for $13.4 billion in cash to Amgen Inc, taking Celgene a step closer to a $74-billion takeover by Bristol-Myers Squibb Co......»»